Publication | Open Access
The first‐in‐human study of CNTO 7160, an anti‐interleukin‐33 receptor monoclonal antibody, in healthy subjects and patients with asthma or atopic dermatitis
36
Citations
17
References
2020
Year
This first-in-human study provides PK, PD and safety data, supporting further clinical investigation of CNTO 7160 in patients with asthma and AD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1